Strategic Fit BrainPulse offers non-invasive skull motion data tied to pulsatile blood flow, enabling clinicians to advance diagnostics for brain disorders. This positions Jan Medical as a potential partner for hospitals and clinics seeking enhanced monitoring for concussion, stroke, aneurysm, AVM, and vasospasm—areas with growing demand for objective diagnostic tools.

Growth Opportunity With 11-50 employees and a recent funding round around seven figures, Jan Medical is in a development and commercialization phase. This presents an opportunity for partnerships, pilot programs, or co-development arrangements with larger hospital networks or device distributors looking to expand neurology-focused offerings.

Regulatory Advantage FDA clearance for cranial motion measurement provides a credible entry point for clinical adoption and potential expansion into new neurological indications. Sales discussions can emphasize regulatory readiness as a risk-reduction factor for hospital buyers evaluating purchasing risk.

Revenue Signal Current revenue range indicates early commercial activity. Partnerships with established medical device distributors or contract manufacturers could accelerate scale, regional deployment, and recurring sales through bundled service packages or data analytics support.

Data and Analytics BrainPulse data platform, combined with clinical experiences across concussion and other conditions, offers a foundation for value-added services such as workflow integration, outcome tracking, and outcomes-based pricing discussions with neurology and critical care departments.